Clinical trial
A Randomized, Controlled Evaluation of the Safety and Efficacy of Topical Treatments for Moderate-Severe Facial Acne Vulgaris
NCT02604680 is registered in ClinicalTrials.gov with Braintree Laboratories as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Controlled Evaluation of the Safety and Efficacy of Topical Treatments for Moderate-Severe Facial Acne Vulgaris
- Lead sponsor
- Braintree Laboratories
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2015
- Completion date
- June 30, 2016
- Enrollment
- 509 (actual)
- Sites
- 50
Conditions
As the registry lists them; a condition with its own page is linked.